Clinical Trial Update: Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing aSpirin with cilostazol for inhibition of antiplatelet aggregation in patients with Type 2 diabetes mellitus. The status is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)
• Cilostazol (Cilostazol)

Snippet

Sponsor: Kangbuk Samsung Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN